ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666113 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666113; 2) Community: the network communities that were significantly associated with the response to NSC 666113; 3) Molecule: the relationships between components within communities and NSC 666113; 4) MDR: the compounds that were significantly associated with the NSC 666113.

NSC Compound Enrichment Correlation
NSC 658387 6,9-Ethanobenzo[g]quinoxaline-5,10-diol, 6,9-dihydro- 2,3-dimethyl- 0.0027236921521653 0.54770608
NSC 665076 1,3-butadiene, 1,1,2,4,4-pentachloro-3-nitro- 0.0027236921521653 0.76664263
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.00286159651545682 0.75023238
NSC 638294 Null 0.00286159651545682 0.61891302
NSC 651590 ANTINEOPLASTIC-651590 0.00286159651545682 0.64594735
NSC 668269 Null 0.00286159651545682 0.59404301
NSC 749147 Null 0.00286159651545682 0.53821112
NSC 81052 Streptonigrin analog (MeO-N3) 0.00286159651545682 0.69415618
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.00293992674122322 0.62368831
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.00293992674122322 0.79804694
Total:130  Current:19    [First] [Prev] [Next] [Last]